oxymetazoline has been researched along with Pain, Postoperative in 5 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Pain, Postoperative: Pain during the period after surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study aimed to determine the effect of oxymetazoline nasal spray on the patency of the fistula created after dacryocystorhinostomy, specifically: to compare the success of fistula formation with oxymetazoline versus placebo, and to compare the incidence of post-operative congestion, pain and bleeding with oxymetazoline versus placebo." | 5.34 | A randomized controlled trial on the effects of oxymetazoline nasal spray after dacryocystorhinostomy among adult patients. ( Lagunzad, JKD; Ranche, FKT; Sosuan, GMN, 2020) |
| "Safety and postoperative pain, range of motion, and self-reported function were evaluated for 90 days." | 2.76 | Novel drug OMS103HP reduces pain and improves joint motion and function for 90 days after arthroscopic meniscectomy. ( Demopulos, GA; ElAttrache, NS; Fox, DL; Garrett, WE; Hewitt, MS; Kaeding, CC; O'Donnell, JB; Papilion, JD; Ruvuna, F; Skrepnik, NV; Whitaker, JS; Xerogeanes, JW, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sosuan, GMN | 1 |
| Ranche, FKT | 1 |
| Lagunzad, JKD | 1 |
| Fanton, GS | 1 |
| Dillingham, MF | 1 |
| Wall, MS | 1 |
| Gillenwater, GE | 1 |
| Khan, AM | 1 |
| Carver, TJ | 1 |
| Perkins, JG | 1 |
| Demopulos, GA | 2 |
| Garrett, WE | 1 |
| Kaeding, CC | 1 |
| ElAttrache, NS | 1 |
| Xerogeanes, JW | 1 |
| Hewitt, MS | 1 |
| Skrepnik, NV | 1 |
| Papilion, JD | 1 |
| O'Donnell, JB | 1 |
| Fox, DL | 1 |
| Ruvuna, F | 1 |
| Whitaker, JS | 1 |
| Siegel, MG | 1 |
| Fischmeister, MF | 1 |
3 trials available for oxymetazoline and Pain, Postoperative
| Article | Year |
|---|---|
A randomized controlled trial on the effects of oxymetazoline nasal spray after dacryocystorhinostomy among adult patients.
Topics: Adult; Aged; Dacryocystorhinostomy; Double-Blind Method; Epistaxis; Female; Fistula; Humans; Male; M | 2020 |
Novel drug product to improve joint motion and function and reduce pain after arthroscopic anterior cruciate ligament reconstruction.
Topics: Adult; Amitriptyline; Analgesics; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; A | 2008 |
Novel drug OMS103HP reduces pain and improves joint motion and function for 90 days after arthroscopic meniscectomy.
Topics: Adolescent; Adult; Aged; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthrosc | 2011 |
2 other studies available for oxymetazoline and Pain, Postoperative
| Article | Year |
|---|---|
Regarding the novel drug OMS103HP.
Topics: Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthroscopy; Female; Humans; Keto | 2012 |
Novel drug in arthroscopic meniscectomy.
Topics: Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthroscopy; Female; Humans; Keto | 2012 |